世界の変形性関節症用鎮痛剤市場予測 2020年-2025年

【英語タイトル】Global Osteoarthritis Pain Drugs Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20AP6588)・商品コード:LPI20AP6588
・発行会社(調査会社):LP Information
・発行日:2020年3月25日(※2024年版があります。お問い合わせください)
・ページ数:160
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「変形性関節症用鎮痛剤の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、経口、注射、外用など、用途別には、医療用、パーソナルケア用などに区分してまとめた調査レポートです。変形性関節症用鎮痛剤のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・変形性関節症用鎮痛剤の世界市場概要(サマリー)
・変形性関節症用鎮痛剤の企業別販売量・売上
・変形性関節症用鎮痛剤の企業別市場シェア
・変形性関節症用鎮痛剤の世界市場規模 2015年-2020年:種類別(経口、注射、外用)
・変形性関節症用鎮痛剤の世界市場規模 2015年-2020年:用途別(医療用、パーソナルケア用)
・変形性関節症用鎮痛剤の米州市場規模(アメリカ、カナダ、メキシコなど)
・変形性関節症用鎮痛剤のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・変形性関節症用鎮痛剤の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・変形性関節症用鎮痛剤の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・変形性関節症用鎮痛剤市場の成長要因・課題・動向
・変形性関節症用鎮痛剤の世界市場予測 2021年-2025年
・変形性関節症用鎮痛剤の米州市場予測(アメリカ、カナダ、メキシコなど)
・変形性関節症用鎮痛剤のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・変形性関節症用鎮痛剤の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・変形性関節症用鎮痛剤の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・変形性関節症用鎮痛剤の世界市場予測:種類別(経口、注射、外用)
・変形性関節症用鎮痛剤の世界市場予測:用途別(医療用、パーソナルケア用)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Osteoarthritis Pain Drugs market will register a 5.9% CAGR in terms of revenue, the global market size will reach $ 10220 million by 2025, from $ 8115 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Osteoarthritis Pain Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Osteoarthritis Pain Drugs market by type, application, key manufacturers and key regions and countries.

This study considers the Osteoarthritis Pain Drugs value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Oral
Injection
External

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Medical Care
Personal Care

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Johnson & Johnson
TEVA
Pfizer
Mylan
Lilly
GlaxoSmithKline
Bayer
Sanofi
Almatica Pharma
Abbott Laboratories
Iroko Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Osteoarthritis Pain Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Osteoarthritis Pain Drugs market by identifying its various subsegments.
Focuses on the key global Osteoarthritis Pain Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Osteoarthritis Pain Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Osteoarthritis Pain Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Osteoarthritis Pain Drugs Consumption 2015-2025
2.1.2 Osteoarthritis Pain Drugs Consumption CAGR by Region
2.2 Osteoarthritis Pain Drugs Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 External
2.3 Osteoarthritis Pain Drugs Consumption by Type
2.3.1 Global Osteoarthritis Pain Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Osteoarthritis Pain Drugs Sale Price by Type (2015-2020)
2.4 Osteoarthritis Pain Drugs Segment by Application
2.4.1 Medical Care
2.4.2 Personal Care
2.5 Osteoarthritis Pain Drugs Consumption by Application
2.5.1 Global Osteoarthritis Pain Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Osteoarthritis Pain Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Osteoarthritis Pain Drugs Sale Price by Type (2015-2020)

3 Global Osteoarthritis Pain Drugs by Company
3.1 Global Osteoarthritis Pain Drugs Sales Market Share by Company
3.1.1 Global Osteoarthritis Pain Drugs Sales by Company (2018-2020)
3.1.2 Global Osteoarthritis Pain Drugs Sales Market Share by Company (2018-2020)
3.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Company
3.2.1 Global Osteoarthritis Pain Drugs Revenue by Company (2018-2020)
3.2.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Osteoarthritis Pain Drugs Sale Price by Company
3.4 Global Osteoarthritis Pain Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Osteoarthritis Pain Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Osteoarthritis Pain Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Osteoarthritis Pain Drugs by Regions
4.1 Osteoarthritis Pain Drugs by Regions
4.2 Americas Osteoarthritis Pain Drugs Consumption Growth
4.3 APAC Osteoarthritis Pain Drugs Consumption Growth
4.4 Europe Osteoarthritis Pain Drugs Consumption Growth
4.5 Middle East & Africa Osteoarthritis Pain Drugs Consumption Growth

5 Americas
5.1 Americas Osteoarthritis Pain Drugs Consumption by Countries
5.1.1 Americas Osteoarthritis Pain Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Osteoarthritis Pain Drugs Value by Countries (2015-2020)
5.2 Americas Osteoarthritis Pain Drugs Consumption by Type
5.3 Americas Osteoarthritis Pain Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Osteoarthritis Pain Drugs Consumption by Regions
6.1.1 APAC Osteoarthritis Pain Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Osteoarthritis Pain Drugs Value by Regions (2015-2020)
6.2 APAC Osteoarthritis Pain Drugs Consumption by Type
6.3 APAC Osteoarthritis Pain Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Osteoarthritis Pain Drugs by Countries
7.1.1 Europe Osteoarthritis Pain Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Osteoarthritis Pain Drugs Value by Countries (2015-2020)
7.2 Europe Osteoarthritis Pain Drugs Consumption by Type
7.3 Europe Osteoarthritis Pain Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Osteoarthritis Pain Drugs by Countries
8.1.1 Middle East & Africa Osteoarthritis Pain Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Osteoarthritis Pain Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Osteoarthritis Pain Drugs Consumption by Type
8.3 Middle East & Africa Osteoarthritis Pain Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Osteoarthritis Pain Drugs Distributors
10.3 Osteoarthritis Pain Drugs Customer

11 Global Osteoarthritis Pain Drugs Market Forecast
11.1 Global Osteoarthritis Pain Drugs Consumption Forecast (2021-2025)
11.2 Global Osteoarthritis Pain Drugs Forecast by Regions
11.2.1 Global Osteoarthritis Pain Drugs Forecast by Regions (2021-2025)
11.2.2 Global Osteoarthritis Pain Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Osteoarthritis Pain Drugs Forecast by Type
11.8 Global Osteoarthritis Pain Drugs Forecast by Application

12 Key Players Analysis
12.1 Johnson & Johnson
12.1.1 Company Information
12.1.2 Osteoarthritis Pain Drugs Product Offered
12.1.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Johnson & Johnson Latest Developments
12.2 TEVA
12.2.1 Company Information
12.2.2 Osteoarthritis Pain Drugs Product Offered
12.2.3 TEVA Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 TEVA Latest Developments
12.3 Pfizer
12.3.1 Company Information
12.3.2 Osteoarthritis Pain Drugs Product Offered
12.3.3 Pfizer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Pfizer Latest Developments
12.4 Mylan
12.4.1 Company Information
12.4.2 Osteoarthritis Pain Drugs Product Offered
12.4.3 Mylan Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Mylan Latest Developments
12.5 Lilly
12.5.1 Company Information
12.5.2 Osteoarthritis Pain Drugs Product Offered
12.5.3 Lilly Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Lilly Latest Developments
12.6 GlaxoSmithKline
12.6.1 Company Information
12.6.2 Osteoarthritis Pain Drugs Product Offered
12.6.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 GlaxoSmithKline Latest Developments
12.7 Bayer
12.7.1 Company Information
12.7.2 Osteoarthritis Pain Drugs Product Offered
12.7.3 Bayer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Bayer Latest Developments
12.8 Sanofi
12.8.1 Company Information
12.8.2 Osteoarthritis Pain Drugs Product Offered
12.8.3 Sanofi Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Sanofi Latest Developments
12.9 Almatica Pharma
12.9.1 Company Information
12.9.2 Osteoarthritis Pain Drugs Product Offered
12.9.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Almatica Pharma Latest Developments
12.10 Abbott Laboratories
12.10.1 Company Information
12.10.2 Osteoarthritis Pain Drugs Product Offered
12.10.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Abbott Laboratories Latest Developments
12.11 Iroko Pharmaceuticals
12.11.1 Company Information
12.11.2 Osteoarthritis Pain Drugs Product Offered
12.11.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Iroko Pharmaceuticals Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Osteoarthritis Pain Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Oral
Table 5. Major Players of Injection
Table 6. Major Players of External
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Osteoarthritis Pain Drugs Consumption Market Share by Type (2015-2020)
Table 9. Global Osteoarthritis Pain Drugs Revenue by Type (2015-2020) ($ million)
Table 10. Global Osteoarthritis Pain Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Osteoarthritis Pain Drugs Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Osteoarthritis Pain Drugs Consumption Market Share by Application (2015-2020)
Table 14. Global Osteoarthritis Pain Drugs Value by Application (2015-2020)
Table 15. Global Osteoarthritis Pain Drugs Value Market Share by Application (2015-2020)
Table 16. Global Osteoarthritis Pain Drugs Sale Price by Application (2015-2020)
Table 17. Global Osteoarthritis Pain Drugs Sales by Company (2017-2019) (M Dose)
Table 18. Global Osteoarthritis Pain Drugs Sales Market Share by Company (2017-2019)
Table 19. Global Osteoarthritis Pain Drugs Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Osteoarthritis Pain Drugs Revenue Market Share by Company (2017-2019)
Table 21. Global Osteoarthritis Pain Drugs Sale Price by Company (2017-2019)
Table 22. Global Osteoarthritis Pain Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Osteoarthritis Pain Drugs Products Offered
Table 24. Osteoarthritis Pain Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Osteoarthritis Pain Drugs Consumption by Regions 2015-2020 (M Dose)
Table 26. Global Osteoarthritis Pain Drugs Consumption Market Share by Regions 2015-2020
Table 27. Global Osteoarthritis Pain Drugs Value by Regions 2015-2020 ($ Millions)
Table 28. Global Osteoarthritis Pain Drugs Value Market Share by Regions 2015-2020
Table 29. Americas Osteoarthritis Pain Drugs Consumption by Countries (2015-2020) (M Dose)
Table 30. Americas Osteoarthritis Pain Drugs Consumption Market Share by Countries (2015-2020)
Table 31. Americas Osteoarthritis Pain Drugs Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Osteoarthritis Pain Drugs Value Market Share by Countries (2015-2020)
Table 33. Americas Osteoarthritis Pain Drugs Consumption by Type (2015-2020) (M Dose)
Table 34. Americas Osteoarthritis Pain Drugs Consumption Market Share by Type (2015-2020)
Table 35. Americas Osteoarthritis Pain Drugs Consumption by Application (2015-2020) (M Dose)
Table 36. Americas Osteoarthritis Pain Drugs Consumption Market Share by Application (2015-2020)
Table 37. APAC Osteoarthritis Pain Drugs Consumption by Countries (2015-2020) (M Dose)
Table 38. APAC Osteoarthritis Pain Drugs Consumption Market Share by Countries (2015-2020)
Table 39. APAC Osteoarthritis Pain Drugs Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Osteoarthritis Pain Drugs Value Market Share by Regions (2015-2020)
Table 41. APAC Osteoarthritis Pain Drugs Consumption by Type (2015-2020) (M Dose)
Table 42. APAC Osteoarthritis Pain Drugs Consumption Market Share by Type (2015-2020)
Table 43. APAC Osteoarthritis Pain Drugs Consumption by Application (2015-2020) (M Dose)
Table 44. APAC Osteoarthritis Pain Drugs Consumption Market Share by Application (2015-2020)
Table 45. Europe Osteoarthritis Pain Drugs Consumption by Countries (2015-2020) (M Dose)
Table 46. Europe Osteoarthritis Pain Drugs Consumption Market Share by Countries (2015-2020)
Table 47. Europe Osteoarthritis Pain Drugs Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Osteoarthritis Pain Drugs Value Market Share by Countries (2015-2020)
Table 49. Europe Osteoarthritis Pain Drugs Consumption by Type (2015-2020) (M Dose)
Table 50. Europe Osteoarthritis Pain Drugs Consumption Market Share by Type (2015-2020)
Table 51. Europe Osteoarthritis Pain Drugs Consumption by Application (2015-2020) (M Dose)
Table 52. Europe Osteoarthritis Pain Drugs Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Osteoarthritis Pain Drugs Consumption by Countries (2015-2020) (M Dose)
Table 54. Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Osteoarthritis Pain Drugs Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Osteoarthritis Pain Drugs Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Osteoarthritis Pain Drugs Consumption by Type (2015-2020) (M Dose)
Table 58. Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Osteoarthritis Pain Drugs Consumption by Application (2015-2020) (M Dose)
Table 60. Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Application (2015-2020)
Table 61. Osteoarthritis Pain Drugs Distributors List
Table 62. Osteoarthritis Pain Drugs Customer List
Table 63. Global Osteoarthritis Pain Drugs Consumption Forecast by Countries (2021-2025) (M Dose)
Table 64. Global Osteoarthritis Pain Drugs Consumption Market Forecast by Regions
Table 65. Global Osteoarthritis Pain Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Osteoarthritis Pain Drugs Value Market Share Forecast by Regions
Table 67. Global Osteoarthritis Pain Drugs Consumption Forecast by Type (2021-2025) (M Dose)
Table 68. Global Osteoarthritis Pain Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Osteoarthritis Pain Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Osteoarthritis Pain Drugs Value Market Share Forecast by Type (2021-2025)
Table 71. Global Osteoarthritis Pain Drugs Consumption Forecast by Application (2021-2025) (M Dose)
Table 72. Global Osteoarthritis Pain Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Osteoarthritis Pain Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Osteoarthritis Pain Drugs Value Market Share Forecast by Application (2021-2025)
Table 75. Johnson & Johnson Product Offered
Table 76. Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2018-2020E)
Table 77. Johnson & Johnson Main Business
Table 78. Johnson & Johnson Latest Developments
Table 79. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. TEVA Product Offered
Table 81. TEVA Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2018-2020E)
Table 82. TEVA Main Business
Table 83. TEVA Latest Developments
Table 84. TEVA Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Pfizer Product Offered
Table 86. Pfizer Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2018-2020E)
Table 87. Pfizer Main Business
Table 88. Pfizer Latest Developments
Table 89. Pfizer Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Mylan Product Offered
Table 91. Mylan Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2018-2020E)
Table 92. Mylan Main Business
Table 93. Mylan Latest Developments
Table 94. Mylan Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Lilly Product Offered
Table 96. Lilly Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2018-2020E)
Table 97. Lilly Main Business
Table 98. Lilly Latest Developments
Table 99. Lilly Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. GlaxoSmithKline Product Offered
Table 101. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2018-2020E)
Table 102. GlaxoSmithKline Main Business
Table 103. GlaxoSmithKline Latest Developments
Table 104. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Bayer Product Offered
Table 106. Bayer Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Bayer Main Business
Table 108. Bayer Latest Developments
Table 109. Bayer Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2018-2020E)
Table 110. Sanofi Product Offered
Table 111. Sanofi Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2018-2020E)
Table 112. Sanofi Main Business
Table 113. Sanofi Latest Developments
Table 114. Sanofi Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Almatica Pharma Product Offered
Table 116. Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2018-2020E)
Table 117. Almatica Pharma Main Business
Table 118. Almatica Pharma Latest Developments
Table 119. Almatica Pharma Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Abbott Laboratories Product Offered
Table 121. Abbott Laboratories Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2018-2020E)
Table 122. Abbott Laboratories Main Business
Table 123. Abbott Laboratories Latest Developments
Table 124. Abbott Laboratories Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Iroko Pharmaceuticals Product Offered
Table 126. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2018-2020E)
Table 127. Iroko Pharmaceuticals Main Business
Table 128. Iroko Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Iroko Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Osteoarthritis Pain Drugs
Figure 2. Osteoarthritis Pain Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Osteoarthritis Pain Drugs Consumption Growth Rate 2015-2025 (M Dose)
Figure 5. Global Osteoarthritis Pain Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Oral
Figure 7. Product Picture of Injection
Figure 8. Product Picture of External
Figure 9. Global Osteoarthritis Pain Drugs Consumption Market Share by Type (2015-2020)
Figure 10. Global Osteoarthritis Pain Drugs Value Market Share by Type (2015-2020)
Figure 11. Osteoarthritis Pain Drugs Consumed in Medical Care
Figure 12. Global Osteoarthritis Pain Drugs Market: Medical Care (2015-2020) (M Dose)
Figure 13. Global Osteoarthritis Pain Drugs Market: Medical Care (2015-2020) ($ Millions)
Figure 14. Osteoarthritis Pain Drugs Consumed in Personal Care
Figure 15. Global Osteoarthritis Pain Drugs Market: Personal Care (2015-2020) (M Dose)
Figure 16. Global Osteoarthritis Pain Drugs Market: Personal Care (2015-2020) ($ Millions)
Figure 17. Global Osteoarthritis Pain Drugs Consumption Market Share by Application (2015-2020)
Figure 18. Global Osteoarthritis Pain Drugs Value Market Share by Application (2015-2020)
Figure 19. Global Osteoarthritis Pain Drugs Sales Market Share by Company in 2017
Figure 20. Global Osteoarthritis Pain Drugs Sales Market Share by Company in 2019
Figure 21. Global Osteoarthritis Pain Drugs Revenue Market Share by Company in 2017
Figure 22. Global Osteoarthritis Pain Drugs Revenue Market Share by Company in 2019
Figure 23. Global Osteoarthritis Pain Drugs Sale Price by Company in 2019
Figure 24. Global Osteoarthritis Pain Drugs Consumption Market Share by Regions 2015-2020
Figure 25. Global Osteoarthritis Pain Drugs Value Market Share by Regions 2015-2020
Figure 26. Americas Osteoarthritis Pain Drugs Consumption 2015-2020 (M Dose)
Figure 27. Americas Osteoarthritis Pain Drugs Value 2015-2020 ($ Millions)
Figure 28. APAC Osteoarthritis Pain Drugs Consumption 2015-2020 (M Dose)
Figure 29. APAC Osteoarthritis Pain Drugs Value 2015-2020 ($ Millions)
Figure 30. Europe Osteoarthritis Pain Drugs Consumption 2015-2020 (M Dose)
Figure 31. Europe Osteoarthritis Pain Drugs Value 2015-2020 ($ Millions)
Figure 32. Middle East & Africa Osteoarthritis Pain Drugs Consumption 2015-2020 (M Dose)
Figure 33. Middle East & Africa Osteoarthritis Pain Drugs Value 2015-2020 ($ Millions)
Figure 34. Americas Osteoarthritis Pain Drugs Consumption Market Share by Countries in 2019
Figure 35. Americas Osteoarthritis Pain Drugs Value Market Share by Countries in 2019
Figure 36. Americas Osteoarthritis Pain Drugs Consumption Market Share by Type in 2019
Figure 37. Americas Osteoarthritis Pain Drugs Consumption Market Share by Application in 2019
Figure 38. United States Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 39. United States Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 40. Canada Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 41. Canada Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 42. Mexico Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 43. Mexico Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 44. APAC Osteoarthritis Pain Drugs Consumption Market Share by Countries in 2019
Figure 45. APAC Osteoarthritis Pain Drugs Value Market Share by Regions in 2019
Figure 46. APAC Osteoarthritis Pain Drugs Consumption Market Share by Type in 2019
Figure 47. APAC Osteoarthritis Pain Drugs Consumption Market Share by Application in 2019
Figure 48. China Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 49. China Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 50. Japan Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 51. Japan Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 52. Korea Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 53. Korea Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 54. Southeast Asia Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 55. Southeast Asia Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 56. India Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 57. India Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 58. Australia Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 59. Australia Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 60. Europe Osteoarthritis Pain Drugs Consumption Market Share by Countries in 2019
Figure 61. Europe Osteoarthritis Pain Drugs Value Market Share by Countries in 2019
Figure 62. Europe Osteoarthritis Pain Drugs Consumption Market Share by Type in 2019
Figure 63. Europe Osteoarthritis Pain Drugs Consumption Market Share by Application in 2019
Figure 64. Germany Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 65. Germany Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 66. France Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 67. France Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 68. UK Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 69. UK Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 70. Italy Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 71. Italy Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 72. Russia Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 73. Russia Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 74. Spain Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 75. Spain Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Osteoarthritis Pain Drugs Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Application in 2019
Figure 80. Egypt Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 81. Egypt Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 83. South Africa Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 85. Israel Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 87. Turkey Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 89. GCC Countries Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 90. Global Osteoarthritis Pain Drugs Consumption Growth Rate Forecast (2021-2025) (M Dose)
Figure 91. Global Osteoarthritis Pain Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 93. Americas Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 94. APAC Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 95. APAC Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 96. Europe Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 97. Europe Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 99. Middle East & Africa Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 100. United States Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 101. United States Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 102. Canada Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 103. Canada Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 104. Mexico Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 105. Mexico Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 106. Brazil Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 107. Brazil Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 108. China Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 109. China Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 110. Japan Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 111. Japan Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 112. Korea Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 113. Korea Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 115. Southeast Asia Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 116. India Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 117. India Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 118. Australia Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 119. Australia Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 120. Germany Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 121. Germany Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 122. France Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 123. France Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 124. UK Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 125. UK Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 126. Italy Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 127. Italy Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 128. Russia Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 129. Russia Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 130. Spain Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 131. Spain Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 132. Egypt Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 133. Egypt Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 134. South Africa Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 135. South Africa Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 136. Israel Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 137. Israel Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 138. Turkey Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 139. Turkey Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 141. GCC Countries Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 142. Johnson & Johnson Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 143. TEVA Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 144. Pfizer Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 145. Mylan Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 146. Lilly Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 147. GlaxoSmithKline Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 148. Bayer Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 149. Sanofi Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 150. Almatica Pharma Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 151. Abbott Laboratories Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 152. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Market Share (2018-2020)


★調査レポート[世界の変形性関節症用鎮痛剤市場予測 2020年-2025年] (コード:LPI20AP6588)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の変形性関節症用鎮痛剤市場予測 2020年-2025年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆